Your browser doesn't support javascript.
loading
The ambitious role of anti angiogenesis molecules: Turning a cold tumor into a hot one.
Nuti, M; Zizzari, I G; Botticelli, A; Rughetti, A; Marchetti, P.
Afiliação
  • Nuti M; Department of Experimental Medicine, University Sapienza, Rome, Italy. Electronic address: marianna.nuti@uniroma1.it.
  • Zizzari IG; Department of Experimental Medicine, University Sapienza, Rome, Italy.
  • Botticelli A; Department of Clinical and Molecular Medicine, University Sapienza, Rome, Italy.
  • Rughetti A; Department of Experimental Medicine, University Sapienza, Rome, Italy.
  • Marchetti P; Department of Clinical and Molecular Medicine, University Sapienza, Rome, Italy.
Cancer Treat Rev ; 70: 41-46, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30077081
ABSTRACT
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice. We here highlight and discuss the need to take advantage of the common immune targets to design combined strategies to increase clinical responses.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Imunoterapia / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Imunoterapia / Neoplasias Renais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2018 Tipo de documento: Article